Genzyme, Isis complete license agreement for cholesterol drug
CAMBRIDGE, Mass. Genzyme and Isis Pharmaceuticals announced Tuesday that they had finished a license and collaboration agreement for mipomersen, a drug candidate designed for patients with high cholesterol.
Under the agreement, Genzyme will pay Isis $175 million in licensing fees. Isis will contribute up to $175 million for development. After that, the two companies will share development costs. Isis may also receive up to $1.5 billion in commercial, development and regulatory milestone payments. Genzyme will have preferred access to future drugs that Isis develops for rare diseases and diseases affecting the central nervous system.
The companies will share profits for the drug, with Genzyme receiving 70 percent and Isis receiving 30 percent. They will split profits equally once revenues on mipomersen reach $2 billion. Genzyme will also be responsible for funding sales and marketing until revenues can cover them.
“Mipomersen is an innovative treatment that has the potential to change the standard of care for severely ill patients whose needs cannot be addressed by current cholesterol-lowering therapies,” said Henri A. Termeer, Genzyme’s chairman and chief executive officer.
Take Care opens two Columbus locations
COLUMBUS , Ohio Take Care Health Systems, which is owned by Walgreens, has opened two in-store health clinics at Walgreens stores in the Columbus area.
Take Care Health Systems now has 15 clinics in the state, including six in the Cincinnati area, seven in the Cleveland area and two in the Columbus area. Additional expansion is planned for the Columbus area this year.
“Take Care Health Clinics have been very well-received in Ohio since opening clinics in Cincinnati and Cleveland late last year,” stated Peter Miller, president and chief executive officer.
Take Care Health Systems is part of Walgreens new Health and Wellness division, alongside Walgreens newly acquired I-trax/CHD Meridian Healthcare and Whole Health Management, providers of worksite health centers that operate under the name Take Care Employer Solutions. Including Take Care Health clinics, the Walgreens Health and Wellness division manages approximately 550 worksite health and wellness centers and retail health clinics.
Take Care Health Systems currently manages 183 clinics in 23 markets throughout 14 states.
Take Care could see 16 new clinics in Colorado by year-end
CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, is expanding its presence in Colorado to include up to 16 clinics by the end of 2008.
The company currently manages three clinics in the Denver area. Additional Colorado expansion will include locations in the Denver area, as well as new markets Boulder-Longmont and Colorado Springs.
“Take Care Health clinics have been very well-received in the Denver area—our first Colorado market—since opening in May,” stated Peter Miller, president and chief executive officer. “Nationwide, Take Care Health providers have offered high-quality, affordable and convenient health care to more than a half a million patients, with exceedingly high patient satisfaction ratings. We believe that residents throughout Colorado will also find value in our patient-first model of care.”
Take Care Health Systems currently manages 181 clinics in 22 markets throughout 14 states.